These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36713073)

  • 1. Technical feasibility of newborn screening for spinal muscular atrophy by next-generation DNA sequencing.
    Shum BOV; Henner I; Cairns A; Pretorius C; Wilgen U; Barahona P; Ungerer JPJ; Bennett G
    Front Genet; 2023; 14():1095600. PubMed ID: 36713073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
    Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
    [No Abstract]   [Full Text] [Related]  

  • 3. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
    Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
    Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of Neonatal UK Dried Blood Spots Using a Duplex SMN1 Screening Assay.
    Adams SP; Gravett E; Kent N; Kricke S; Ifederu A; Scoto M; Samsuddin S; Muntoni F
    Int J Neonatal Screen; 2021 Oct; 7(4):. PubMed ID: 34842601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
    Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
    Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot Study on Newborn Screening for Spinal Muscular Atrophy.
    Fonseca H; Ribeiro D; Guimarães F; Pinto C; Marcão A; Sousa C; Carvalho I; Lopes L; Rodrigues D; Rocha H; Vilarinho L
    Endocr Metab Immune Disord Drug Targets; 2023 Sep; ():. PubMed ID: 37711122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing.
    Feng Y; Ge X; Meng L; Scull J; Li J; Tian X; Zhang T; Jin W; Cheng H; Wang X; Tokita M; Liu P; Mei H; Wang Y; Li F; Schmitt ES; Zhang WV; Muzny D; Wen S; Chen Z; Yang Y; Beaudet AL; Liu X; Eng CM; Xia F; Wong LJ; Zhang J
    Genet Med; 2017 Aug; 19(8):936-944. PubMed ID: 28125085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried Blood Spot Screening System for Spinal Muscular Atrophy with Allele-Specific Polymerase Chain Reaction and Melting Peak Analysis.
    Wijaya YOS; Nishio H; Niba ETE; Shiroshita T; Kato M; Bouike Y; Tode C; Ar Rochmah M; Harahap NIF; Nurputra DK; Okamoto K; Saito T; Takeuchi A; Lai PS; Yamaguchi S; Shinohara M
    Genet Test Mol Biomarkers; 2021 Apr; 25(4):293-301. PubMed ID: 33877896
    [No Abstract]   [Full Text] [Related]  

  • 10. Newborn screening for spinal muscular atrophy in Japan: One year of experience.
    Sawada T; Kido J; Sugawara K; Yoshida S; Ozasa S; Nomura K; Okada K; Fujiyama N; Nakamura K
    Mol Genet Metab Rep; 2022 Sep; 32():100908. PubMed ID: 35942129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals.
    Bowen BM; Truty R; Aradhya S; Bristow SL; Johnson BA; Morales A; Tan CA; Westbrook MJ; Winder TL; Chavez JC
    Front Neurol; 2021; 12():663911. PubMed ID: 34025568
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years.
    Kimizu T; Nozaki M; Okada Y; Sawada A; Morisaki M; Fujita H; Irie A; Matsuda K; Hasegawa Y; Nishi E; Okamoto N; Kawai M; Imai K; Suzuki Y; Wada K; Mitsuda N; Ida S
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA.
    Ar Rochmah M; Harahap NIF; Niba ETE; Nakanishi K; Awano H; Morioka I; Iijima K; Saito T; Saito K; Lai PS; Takeshima Y; Takeuchi A; Bouike Y; Okamoto M; Nishio H; Shinohara M
    Brain Dev; 2017 Oct; 39(9):774-782. PubMed ID: 28522225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy.
    Strunk A; Abbes A; Stuitje AR; Hettinga C; Sepers EM; Snetselaar R; Schouten J; Asselman FL; Cuppen I; Lemmink H; van der Pol WL; Engel H
    Int J Neonatal Screen; 2019 Jun; 5(2):21. PubMed ID: 33072980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry.
    Tesorero R; Janda J; Hörster F; Feyh P; Mütze U; Hauke J; Schwarz K; Kunz JB; Hoffmann GF; Okun JG
    PLoS One; 2023; 18(3):e0283024. PubMed ID: 36897914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry.
    Lin Y; Lin CH; Yin X; Zhu L; Yang J; Shen Y; Yang C; Chen X; Hu H; Ma Q; Shi X; Shen Y; Hu Z; Huang C; Huang X
    Front Genet; 2019; 10():1255. PubMed ID: 31921298
    [No Abstract]   [Full Text] [Related]  

  • 18. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E49-E53. PubMed ID: 31956256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
    Kay DM; Stevens CF; Parker A; Saavedra-Matiz CA; Sack V; Chung WK; Chiriboga CA; Engelstad K; Laureta E; Farooq O; Ciafaloni E; Lee BH; Malek S; Treidler S; Anziska Y; Delfiner L; Sakonju A; Caggana M
    Genet Med; 2020 Aug; 22(8):1296-1302. PubMed ID: 32418989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR.
    Takeuchi A; Tode C; Nishino M; Wijaya YOS; Niba ETE; Awano H; Takeshima Y; Saito T; Saito K; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Nov; 65(3):E95-E99. PubMed ID: 32029694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.